MedPath

Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education

Not Applicable
Completed
Conditions
Arrhythmia
Interventions
Behavioral: Intervention
Registration Number
NCT00845234
Lead Sponsor
East Carolina University
Brief Summary

An implantable cardioverter defibrillator (ICD) administers a shock to terminate potentially life-threatening cardiac arrhythmias. The device saves lives, but presents psychological challenges for patients. At present, there is a paucity of brief interventions for ICD patients designed for administration in a clinic setting that considers issues of cost, time, and available resources. The present study examined the impact of a brief cognitive behavioral (CBT) educational intervention on primary endpoints of patient acceptance and quality of life and secondary endpoints of depression and anxiety. It was hypothesized that the intervention would result in significant improvements primary and secondary endpoints for participants in the intervention group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • 18+ years old
  • literate
  • newly implanted with an implantable cardioverter defibrillator (ICD)
Exclusion Criteria
  • documented neurological sequelae associated with CVA or dementia
  • documented cognitive impairment
  • reported illiteracy
  • previously implanted ICD

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupInterventionIntervention group- Patients will receive the brief educational CBT intervention + video and Q\&A session
Primary Outcome Measures
NameTimeMethod
Score on measure assessing construct of quality of lifeUp to 8 months after enrollment

Quality of life will be obtained via participants scores from the Medical Outcomes Survey Short Form-12 (SF-12) measure of quality of life.

Secondary Outcome Measures
NameTimeMethod
Score on measure assessing depressionUp to 8 months after enrollment

Depression will be assessed via participant's self-reported scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS).

score on measure assessing construct of patient acceptance of deviceup to 8 months after enrollment

The Florida Patient Acceptance Scale measures patient's self-reported acceptance of the implantable cardioverter defibrillator.

score on measure assessing anxietyUp to 8 months after enrollment

The Hospital Anxiety and Depression Scale is comprised of two subscales- anxiety and depression. It is a self-report measure that generates a score on the patient's current level of anxiety.

Trial Locations

Locations (2)

East Carolina Heart Institute

🇺🇸

Greenville, North Carolina, United States

Aurora Denver Cardiology Associates

🇺🇸

Lone Tree, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath